Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 |
filingDate |
1997-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b130b2fb0f0af69eccaf55d22a419e |
publicationDate |
1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-9902135-A2 |
titleOfInvention |
Use of (+) - alpha- (2,3-Dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinium methanol for the manufacture of a medicament for the treatment of depressive and bipolar disorders |
abstract |
The present invention relates to the use of (+) -? - (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidine methane, or a pharmaceutically acceptable acid addition salt thereof, optionally with a pharmaceutically acceptable bath. mixed to form a medicament for the treatment of depressive and bipolar disorder. ŕ |
priorityDate |
1996-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |